A phase Ib study administering rapamycin [sirolimus] with grapefruit juice in patients with advanced malignancies
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2014
At a glance
- Drugs Sirolimus (Primary)
- Indications Chronic lymphocytic leukaemia; Lymphoma; Multiple myeloma
- Focus Pharmacokinetics
- 22 Jun 2012 Planned end date changed from 1 Nov 2009 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 12 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Feb 2009 Planned end date changed from 1 Nov 2008 to 1 Nov 2009 as reported by ClinicalTrials.gov.